Cover Image
市場調查報告書

VivaCell Biotechnology Espana S.L.:產品平台分析

VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 320001
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
VivaCell Biotechnology Espana S.L.:產品平台分析 VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015
出版日期: 2015年12月16日 內容資訊: 英文 26 Pages
簡介

VivaCell Biotechnology Espana S.L. 是神經退化性疾病和慢性的發炎性疾病治療的phytocannabinoid衍生物的開發專門的生物製藥公司。該公司還有以製藥公司為首,提供食品、化妝品公司委託研究組織服務。

本報告提供VivaCell Biotechnology Espana S.L.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

VivaCell Biotechnology Espana S.L.的基本資料

  • VivaCell Biotechnology Espana S.L.概要
  • 主要資訊
  • 企業資料

VivaCell Biotechnology Espana S.L.:R&D概要

  • 主要的治療範圍

VivaCell Biotechnology Espana S.L.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

VivaCell Biotechnology Espana S.L.:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

VivaCell Biotechnology Espana S.L.:藥物簡介

  • CDE-001
  • VCE-003
  • VCE-0032
  • VCE-0048

VivaCell Biotechnology Espana S.L.:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

VivaCell Biotechnology Espana S.L.:最近的開發平台趨勢

VivaCell Biotechnology Espana S.L.:暫停中的計劃

VivaCell Biotechnology Espana S.L.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07876CDB

Summary

Global Markets Direct's, 'VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015', provides an overview of the VivaCell Biotechnology Espana S.L.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of VivaCell Biotechnology Espana S.L.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of VivaCell Biotechnology Espana S.L. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of VivaCell Biotechnology Espana S.L.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the VivaCell Biotechnology Espana S.L.'s pipeline products

Reasons to buy

  • Evaluate VivaCell Biotechnology Espana S.L.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of VivaCell Biotechnology Espana S.L. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the VivaCell Biotechnology Espana S.L.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of VivaCell Biotechnology Espana S.L. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of VivaCell Biotechnology Espana S.L.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of VivaCell Biotechnology Espana S.L. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • VivaCell Biotechnology Espana S.L. Snapshot
    • VivaCell Biotechnology Espana S.L. Overview
    • Key Information
    • Key Facts
  • VivaCell Biotechnology Espana S.L. - Research and Development Overview
    • Key Therapeutic Areas
  • VivaCell Biotechnology Espana S.L. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • VivaCell Biotechnology Espana S.L. - Pipeline Products Glance
    • VivaCell Biotechnology Espana S.L. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • VivaCell Biotechnology Espana S.L. - Drug Profiles
    • CDE-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCE-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCE-0032
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCE-0048
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • VivaCell Biotechnology Espana S.L. - Pipeline Analysis
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Target
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Route of Administration
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Molecule Type
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Mechanism of Action
  • VivaCell Biotechnology Espana S.L. - Recent Pipeline Updates
  • VivaCell Biotechnology Espana S.L. - Dormant Projects
  • VivaCell Biotechnology Espana S.L. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • VivaCell Biotechnology Espana S.L., Key Information
  • VivaCell Biotechnology Espana S.L., Key Facts
  • VivaCell Biotechnology Espana S.L. - Pipeline by Indication, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Stage of Development, 2015
  • VivaCell Biotechnology Espana S.L. - Monotherapy Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Partnered Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Partnered Products/ Combination Treatment Modalities, 2015
  • VivaCell Biotechnology Espana S.L. - Preclinical, 2015
  • VivaCell Biotechnology Espana S.L. - Discovery, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Target, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Route of Administration, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Molecule Type, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline Products by Mechanism of Action, 2015
  • VivaCell Biotechnology Espana S.L. - Recent Pipeline Updates, 2015
  • VivaCell Biotechnology Espana S.L. - Dormant Developmental Projects,2015

List of Figures

  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Indication, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Stage of Development, 2015
  • VivaCell Biotechnology Espana S.L. - Monotherapy Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Partnered Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Target, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Route of Administration, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Molecule Type, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top